Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.

Clinical breast cancer - 1 Oct 2018

Da Ros Lucia, Moretti Anna, Querzoli Patrizia, Pedriali Massimo, Lupini Laura, Bassi Cristian, Carcoforo Paolo, Negrini Massimo, Frassoldati Antonio

Abstract excerpt

BACKGROUND: Infiltrating lobular carcinoma (ILC) represents about 10% of breast cancer and rarely shows overexpression of human epidermal growth factor receptor 2 (HER2). We compared biological and clinical characteristics of HER2-positive ILC versus HER2-positive infiltrating ductal carcinoma (IDC). PATIENTS AND METHODS: We retrospectively analyzed the data of 328 patients with HER2-positive pure ductal or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Carcinoma, Lobular

Share to Disease-Free Survival

Share to Neoplasm Recurrence, Local

Share to Receptor, ErbB-2

Share to Trastuzumab

Source

Identifiers

PMID: 29759595
DOI: 10.1016/j.clbc.2018.04.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.PMID 29759595Read ↗

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.Semantic proximity Read ↗

Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.Semantic proximity Read ↗

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsSemantic proximity Read ↗

Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastSemantic proximity Read ↗

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.Semantic proximity Read ↗

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.Semantic proximity Read ↗

ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high‐risk characteristics by molecular expression profilingSemantic proximity Read ↗

Case report: Characterization of the immunologic and molecular landscape in a unique presentation of invasive lobular carcinoma with concurrent uterine carcinosarcoma treated with immunotherapy.Semantic proximity Read ↗

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.Semantic proximity Read ↗

ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.Semantic proximity Read ↗

Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.Semantic proximity Read ↗

Genomic Characterization of Primary Invasive Lobular Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.